|
|
| MRD / Regn No. |
: SG000121 |
Date |
: 14/07/2026 |
| Patient Name |
: Ashima Mondal |
Age & Gender |
: 40 Yrs. / Female |
| Contact No. |
: 8100083100 |
UHID |
: |
| Ht / Wt / BMI |
: 152 / 60 / 25.97 |
BP S / BP D |
: 119 / 76 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (08/Aug/2020) | |
| Salient Investigations |
: |
CREATININE: 0.9 | EGFR EGLOMERULAR FILTRATION RATE: 74.22 mL/min/1.73m2 | HB HEMOGLOBIN: 12.4 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 7.87 % | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + LINAGLIPTIN 5 MG ZEXRIDA L |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
2 |
ANTIHYPERGLYCEMIC GLICLAZIDE 60 MG + METFORMIN 500 MG SECGLY M XR |
PO |
1-0-1 |
BEFORE BREAKFAST AND DINNER
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 14/Jan/2027 |
| Tests Suggested For Next Visit |
: HBA1C-HPLC METHOD,CREATININE,UACR:SPOT SAMPLE,RETINA CHECK UP,ECG (ALL LEADS),LIPID PROFILE (RANDOM) |
| |
|
| |
|